Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor

Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor

Background: Pretreatment assessment of patients diagnosed with localized prostate cancer (PCa) is essential for therapeutic decision-making. Currently available staging systems based on prostate-specific antigen (PSA), Gleason score, and clinical stage allow for determining the prognostic characteri...

Full description

Bibliographic Details
Main Authors:	Roser Vives Dilme, Juan Gómez Rivas, Laura Fernández Hernández, Irene De la Parra Sánchez, Rafael Sánchez del Hoyo, María Isabel Galante Romo, Enrique Redondo González, José Luis Senovilla Pérez, Lorena Fernández Montarroso, Jesús Moreno Sierra
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-02-01
Series:	Therapeutic Advances in Urology
Online Access:	https://doi.org/10.1177/17562872241229250

Similar Items

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01)

Role of Liquid Biopsy in Progressive PSA Patients after Radical Prostatectomy
by: Marcel Figueras, et al.
Published: (2024-10-01)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
by: Wafa Asha, MD, et al.
Published: (2023-11-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
by: Antonio B. Porcaro, et al.
Published: (2016-03-01)

Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy.
by: Won Sik Jang, et al.
Published: (2016-01-01)

Predictive model for PSA persistence after radical prostatectomy using machine learning algorithms
by: Haotian Du, et al.
Published: (2024-12-01)

Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy
by: Marbele S. Guimaraes, et al.
Published: (2008-02-01)

Radical prostatectomy in elderly men: Oncological, functional and complication results
by: C. Abeijon Pineiro, et al.
Published: (2020-07-01)

Impacts on functional and oncological outcomes of Robotic-assisted Radical Prostatectomy 10 years after the US Preventive Service Taskforce recommendations against PSA screening
by: Marcio Covas Moschovas, et al.
Published: (2024-04-01)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
by: Desgrandchamps François, et al.
Published: (2008-01-01)

Laparoscopic radical prostatectomy versus robot-assisted radical prostatectomy: comparison of oncological outcomes at a single center
by: Takatsugu Okegawa, et al.
Published: (2020-03-01)

Impact of Sarcopenia on Functional and Oncological Outcomes After Radical Prostatectomy
by: Markus Angerer, et al.
Published: (2021-02-01)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
by: Hamdy, FC, et al.
Published: (2020)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT
by: Freddie C Hamdy, et al.
Published: (2020-08-01)

Seminal vesicle sparing robotic radical prostatectomy – no different interpretation of postoperative PSA follow-up required?
by: Patrick Betschart, et al.
Published: (2019-01-01)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
by: Shyam K. Tanguturi, et al.
Published: (2014-01-01)

Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?
by: Serkan Akan, et al.
Published: (2022-10-01)

Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy
by: Andreas Bohle
Published: (2010-02-01)

Prospective evaluation of radical prostatectomy without prior biopsy based on PSA or DRE, mpMRI and PSMA-PET
by: C. Stief, et al.
Published: (2023-11-01)

Outcome of laparoscopic radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level > 50 ng/ml: A single surgeon experience
by: Yen-Hsi Lee, et al.
Published: (2016-06-01)

Correlation between tumor extent in radical prostatectomies and preoperative PSA, histological grade, surgical margins, and extraprostatic extension: application of a new practical method for tumor extent evaluation
by: Athanase Billis, et al.
Published: (2003-04-01)

The effect of surgical margin features on oncologic outcomes after radical prostatectomy
by: Mubariz Aydamirov, et al.
Published: (2024-08-01)

Appraisal of the role of radical prostatectomy for rhabdomyosarcoma in children: oncological and urological outcome
by: Lorenzo Angelini, et al.
Published: (2018-06-01)

Oncological outcomes of high-risk prostate cancer patients between robot-assisted laparoscopic radical prostatectomy and laparoscopic radical prostatectomy in Taiwan
by: Chieh-Chun Liao, et al.
Published: (2018-01-01)

Laparoscopic radical prostatectomy with no anastomosis
by: Dario Vazquez-Martul, et al.
Published: (2019-11-01)

Prognostic significance of a novel indicator (PSApostd3/PSApre) for PSA recurrence in patients after radical prostatectomy
by: Zhou Z, et al.
Published: (2019-06-01)

68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
by: Yuigi Yuminaga, et al.
Published: (2021-04-01)

Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.
by: Minyong Kang, et al.
Published: (2015-01-01)

Preoperative nutritional evaluation of prostate cancer patients undergoing laparoscopic radical prostatectomy.
by: Wang Shu, et al.
Published: (2022-01-01)

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
by: O'Brien, M, et al.
Published: (2009)

Comparison of the Oncological and Functional Outcomes of Brachytherapy and Radical Prostatectomy for Localized Prostate Cancer
by: Fei Wang, et al.
Published: (2022-10-01)

Robot-assisted radical perineal prostatectomy: one-year functional and oncological outcomes
by: A. Vitarelli, et al.
Published: (2020-10-01)

Oncological outcomes of patients with ductal adenocarcinoma of the prostate receiving radical prostatectomy or radiotherapy
by: Mengzhu Liu, et al.
Published: (2021-04-01)

Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour
by: Elteza Tahjiba Jahir, et al.
Published: (2017-03-01)

Analysis of risk factors for persistent PSA after radical prostatectomy: results from a high-volume center in Southeast China
by: Sida Hao, et al.
Published: (2024-08-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
by: Baruffi Marco, et al.
Published: (2004-04-01)

Preoperative prostate magnetic resonance imaging does not impact surgical outcomes of radical prostatectomy
by: Christopher K. Bozorgmehr, et al.
Published: (2024-10-01)